Demeclocycline HCl Rx
Generic Name and Formulations:
Demeclocycline HCl 150mg, 300mg; tabs.
Various generic manufacturers
Indications for Demeclocycline HCl:
Tetracycline-sensitive infections, including respiratory, genitourinary, skin and skin structure, soft tissues, and those caused by rickettsiae and Mycoplasma pneumoniae; also cholera, psittacosis, plague, shigellosis.
Take with fluids, 1hr before or 2hrs after meals. 150mg 4 times daily or 300mg twice daily. Gonorrhea patients sensitive to penicillin: initially 600mg followed by 300mg every 12hrs for 4 days to a total of 3g.
<8yrs: not recommended. Take with fluids, 1hr before or 2hrs after meals. ≥8yrs: 7–13mg/kg/day divided into 2–4 doses; max 600mg/day.
Renal or hepatic impairment. Monitor blood, renal and hepatic function in long-term use. Avoid sun and UV light. Discontinue if skin erythema occurs. Pregnancy (Cat.D), nursing mothers: not recommended.
Avoid methoxyflurane, photosensitizing agents. May antagonize bactericidal antibiotics; avoid. Reduced absorption with antacids, iron, zinc, calcium, magnesium, dairy products, urinary alkalinizers, other multivalent cations. May reduce effectiveness of oral contraceptives. Monitor prothrombin time with oral anticoagulants.
Photosensitivity, GI upset, rash, blood dyscrasias, increased BUN, hepatotoxicity, C. difficile associated diarrhea, pseudotumor cerebri; rare: esophagitis and esophageal ulceration.
Formerly known under the brand name Declomycin.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies